Skip to main content

Singapore's GIS Taps BT Group's Cloud for NGS Analysis

NEW YORK (GenomeWeb) – A*STAR's Genome Institute of Singapore (GIS) has tapped the BT Group's cloud compute infrastructure to support its existing genome analysis capabilities.

Under the terms of the agreement, GIS will have access to the BT Cloud Compute infrastructure, which is built on the BT for Life Sciences platform, and will use the system to run compute-intensive workloads. It will help GIS speed up efforts to develop commercial and clinical applications for analyzing NGS data as well as efforts to develop algorithms that can be used to explore disease etiologies, GIS Executive Director Ng Huck Hui said in statement.

GIS Chief Scientific Computing Officer Fu Zhiyan added that the deal "extends our in-house infrastructure to support surges in computational demand" and can also "deliver GIS's algorithms to researchers worldwide and enrich the institute's contributions to global research collaborations."

Financial and other terms of the agreement were not disclosed.


The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.